Plasma medicine in dermatology: Basic antimicrobial efficacy testing as prerequisite to clinical plasma therapy

Plasma Medicine

Volumn 2, Issue 1-3, 2012, Pages 33-69

  Daeschlein, Georg ^a   Scholz, Sebastian ^a   Emmert, Steffen ^b   von Podewils, Sebastian ^a   Haase, Hermann ^a   von Woedtke, Thomas ^c   Jünger, Michael ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

Author keywords

Antisepsis; Atmospheric low pressure plasma jet (APPJ); Candida spp; Demodex folliculorum; Dermatomycosis; Dielectric barrier discharge (DBD); Folliculitis; Fungi; Microsporon; MRSA; Plasma medicine; Skin and wound pathogens; Skin infection; Tinea pedis; Trichophyton; Trichophyton mentagrophytis var. interdigitale

Indexed keywords

ANTISEPSIS; CANDIDA SPP; DEMODEX FOLLICULORUM; DERMATOMYCOSIS; DIELECTRIC BARRIER DISCHARGES; FOLLICULITIS; LOW PRESSURE PLASMA; MICROSPORON; MRSA; PLASMA MEDICINES; SKIN INFECTION; TINEA PEDIS; TRICHOPHYTON; TRICHOPHYTON MENTAGROPHYTIS VAR. INTERDIGITALE; WOUND PATHOGENS;

FUNGI;

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; METRONIDAZOLE;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CHRONIC WOUND; DANDRUFF; DECUBITUS; DEMODEX FOLLICULORUM; DERMATOLOGY; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROSPORUM CANIS; NONHUMAN; ONYCHOMYCOSIS; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; ROSACEA; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS; STREPTOCOCCUS GROUP A; TINEA PEDIS; TRICHOPHYTON INTERDIGITALE; TRICHOPHYTON RUBRUM;

EID: 84907993579     PISSN: 19475764     EISSN: 19475772     Source Type: Journal    
DOI: 10.1615/PlasmaMed.2014006217     Document Type: Article

References (68)

1. Brandenburg R, Ehlbeck J, Stieber M, von Woedtke T, Zeymer J, Schlüter O, Weltmann KD. Antimicrobial treatment of heat sensitive materials by means of atmospheric pressure Rfdriven plasma jet. Contrib Plasma Phys. 2007;47:72-9.
2. Fridman G, Brooks A., Balasubramanian M, Fridman A, Gutsol A, Vasilets VN, Ayan H, Friedman G. Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Process Polym. 2007;4:370-5.
3. Daeschlein G, von Woedtke T, Kindel E, Brandenburg R, Weltmann KD, Jünger M. Antibacterial activity of atmospheric pressure plasma jet (APPJ) against relevant wound pathogens in vitro on simulated wound environment. Plasma Process Polym. 2009;6:224-30.
4. Gostev VA, Ignakhin VS, Popova EK, Ostashkov OA. Cold Plasma-a powerful agent for biological applications. in: Güçeri S, Fridman A, Gibson K, Haas C, editors. Plasma assisted decontamination of biological and chemical agents. Dordrecht: Springer 2008; p 65-77
5. Stoffels E, Kieft IE, Sladek REJ, van den Bedem LJM, van der Laan EP, Steinbruch M. Plasma needle for in vivo medical treatment: recent developments and perspectives. Plasma Sources Sci Technol. 2006;15:169-80.
6. Daeschlein G, Scholz S, von Woedtke T, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Jünger M. In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet. IEEE Trans Plasma Sci. 2011;39:815-21.
7. Lademann O, Richter H, Patzelt A, Alborova A, Humme D, Weltmann KD, Hartmann B, Hinz P, Kramer A, Koch S. Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy. Laser Phys Lett. 2010;7:458-62.
8. Lademann J, Richter H, Alborova A, Humme D, Patzelt A, Kramer A, Weltmann KD, Hartmann B, Ottomann C, Fluhr JW, Hinz P, Hubner G, Lademann O. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt. 2009;14:054025.
9. Stoffels E. Cold plasma treatment in wound care: efficacy and risk assessment. 60th Gaseous Electronics Conference. American Physical Society, Arlington. Oct 2007.
10. Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers. Int J Dermatol. 1999;38:573-8.
11. Melendez JH, Frankel YM, An AT, Williams L, Price LB, Wang NY, Lazarus GS, Zenilman JM. Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds. Clin Microbiol Infect. 2010;16:1762-9.
12. Isbary G, Morfill G, Schmidt HU, Georgi M, Ramrath K, Heinlin J, Karrer S, Landthaler M, Shimizu T, Steffes B, Bunk W, Monetti R, Zimmermann JL, Pompl R, Stolz W. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163:78-82.
13. Engemann JJ, Carmelii Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-8.
14. Pollard TC, Newman JE, Barlow NJ, Price JD, Willet KM. Deep wound infection after proximal femoral fracture: consequences and costs. J Hosp Infect. 2006;63:133-9.
15. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilatorassociated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999;160:608-13.
16. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-9.
17. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166-74.
18. Wijaya L, Hsu LY, Kurup A. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann Acad Med Singapore. 2006;35:479-86.
19. Harbarth S, Pittet D. MRSA—a European currency of infection control. An International Journal of Medicine (Q J Med). 1998;91:519-21.
20. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocagöz S, Öztop AY, Vandenbroucke-Grauls CMJE, Harbarth S, Pittet D. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2005;5:653-63.
21. European Antimicrobial Resistance Surveillance System. Susceptibility results for S. aureus isolates in 2005. [cited 2008 May 29]. Available from: http://www.rivm.nl/earss/database/
22. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43:971-8.
23. Dow G, Field D, Mancuso M, Allard J. Decolonization of methicillin-resistant Staphylococcus aureus during routine hospital care: efficacy and long-term follow-up. Can J Infect Dis Med Microbiol. 2010;21:38-44.
24. Lucet JC, Regnier B. Screening and Decolonization: Does Methicillin-Susceptible Staphylococcus aureus Hold Lessons for Methicillin-Resistant S. aureus? Clin Infect Dis. 2010;51:585-90.
25. McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus. Pharmacotherapy. 2009;29:263-80.
26. Daeschlein G, Scholz S, Arnold A, von Woedtke T, Kindel E, Niggemeier M, Weltmann KD, Juünger M. In vitro activity of atmospheric pressure plasma jet (APPJ) against clinical isolates of Demodex folliculorum. IEEE Trans Plasma Sci. 2010;38:2969-73.
27. Orrico M, Naumova Y, Yin SM, Houston E. Biological and medical application of atmospheric plasmas. GMS Krankenhhyg Interdiszip. 2008;3:Doc09.
28. Heinlin J, Isbary G, Stolz W, Morfill G, Landthaler M, Shimizu T, Steffes B, Nosenko T, Zimmermann J, Karrer S. Plasma applications in medicine with a special focus on dermatology. Journal of the European Academy of Dermatology and Venereology (J Eur Acad Dermatol Venerol). 2011;25:1-11.
29. Dobrynin D, Fridman G, Friedman G, Fridman A. Physical and biological mechanisms of direct plasma interaction with living tissue. New J Phys. 2009;11:1-26.
30. Haneke E, Nolting S, Seebacher C, Abeck D, Reinel D. Neue Erkenntnisse zur Epidemiologie von Fußerkrankungen. in Plettenberg A, Meigel WN and Moll I, editors. Dermatologie an der Schwelle zum neuen Jahrtausend. New York: Springer; 2000. p. 377-8.
31. Abeck D, Haneke E, Nolting S, Reinel D, Seebacher C. Onychomykose. Dt Ärztebl. 2000;97:1984-6.
32. Mercantini R, Moretto D, Palmara G, Mercantini P, Massala R. Epidemiology of dermatophytes observed in Rome, Italy, between 1985 and 1993. Mycoses. 1995;38:415-9.
33. Seebacher C, Bouchara JP, Mignon B. Updates on the Epidemiology of Dermatophyte Infections. Mycopathologia. 2008;166:335-52.
34. Faergemann J. The role of yeasts in onychomycosis. Mycoses. 1996;39:223-4.
35. Fridman G, Shereshevsky A, Peddinghaus M, Gutsol A, Vasilets V, Brooks A. Balasubramanian M, Friedman G, Fridman A. Bio-medical applications of non-thermal atmospheric pressure plasma. In: 37th AIAA Plasmadynamics and Laser Conference, San Francisco, 2006.
36. Daeschlein G, Scholz S, Arnold A, von Podewils S, Haase H, Emmert S, von Woedtke T, Weltmann KD, Jünger M. In Vitro Susceptibility of Important Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD). Plasma Process Polym. 2012;9:380-9
37. Weltmann KD, Kindel E, Brandenburg R, Meyer C, Bussiahn R, Wilke C, von Woedtke T. Atmospheric pressure plasma jet for medical therapy: Plasma parameters and risk estimation. Contrib. Plasma Phys. 2009;49:631-40.
38. Kuchenbecker M, Bibinov N, Kaemling A, Wandke D, Awakowicz P, Vioel. Characterization of DBD plasma source for biomedical applications. J Phys D. 2009;42:045212.
39. Helmke A, Hoffmeister D, Mertens N, Emmert S, Schuette J, Vioel W. The acidification of lipid film surfaces by non-thermal DBD at atmospheric pressure air. New J Phys. 2009;11:115025.
40. Meinhof W. Isolierung und Identifizierung von Dermatophyten. Zentralbl Bakteriol. 1990;273:229-45.
41. Fridman G, Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process Polym. 2008;5:503-33.
42. Iza F, Kim GJ, Lee SM, Lee JK, Walsh JL, Zhang YT, Kong MG. Microplasmas: sources, particle kinetics, and biomedical applications. Plasma Process Polym. 2008;5:322-44.
43. Daeschlein G, Napp M, von Podewils S, Lutze S, Emmert S, Lange A, Klare I, Haase H, Gümbel D, von Woedtke T, Jünger M. In Vitro Susceptibility of Multidrug Resistant Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma(DBD). Plasma Processes Polym. 2014; 11: 175-183.
44. Laroussi M. Mechanisms of interaction of cold plasma with bacteria. Fifth International Conference on the Physics of Dusty Plasmas, Ponta Delgada, Azores; 2008 May 18-23.
45. Daeschlein G, Scholz S, Ahmed R, Majumdar A, von Woedtke T, Haase H, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Jünger M. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. Journal der Deutschen Dermatologischen Gesellschaft (J Dtsch Dermatol Ges). 2012;10:509-15.
46. Daeschlein G, Scholz S, Ahmed R, von Woedtke T, Haase H, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Jünger M. Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Inf. 2012;81:177-83.
47. Morfill GE, Shimizu T, Steffes B, Schmidt HU. Nosocomial infections-a new approach towards preventive medicine using plasmas. New J Phys. 2009;11:115019.
48. Lee KY, Park BJ, Lee DH, Lee IS, Hyun SO, Chung KH, Park JC. Sterilization of Escherichia coli and MRSA using microwave-induced argon plasma at atmospheric pressure Surface and Coatings. Technology. 2005;193:35-8.
49. Joshi SG, Paff M, Friedman G, Fridman G, Fridman A, Brooks AD. Control of methicillin-resistant Staphylococcus aureus in planktonic form and biofilms: a biocidal efficacy study of nonthermal dielectric-barrier discharge plasma. Am J Infect Control. 2010;38:293-301.
50. Burts ML, Alexeff I, Meek ET, McCullers JA. Use of atmospheric non-thermal plasma as a disinfectant for objects contaminated with methicillin-resistant Staphylococcus aureus. Am J Infect. 2009;37:729-33.
51. Kong MG, Kroesen G, Morfill G, Nosenko T, Shimizu T, van Dijk J, Zimmermann JL. Plasma medicine: an introductory review. New J. Phys 2009; doi: 10.1088/1367-2630/11/11/115012.
52. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004;17:863-93.
53. Working Group “Hygiene in Hospital & Practice” of AWMF Händedesinfektion und Händehygiene. AWMF Guideline. HygMed. 2008;33:300-13.
54. Gaunt LF, Beggs CB, Georghiou GE. Bactericidal action of the reactive species produced by gas-discharge nonthermal plasma at atmospheric pressure: a review. IEEE Trans Plasma Sci. 2006;34:1257-69.
55. Shulutko AM, Antropova NV, Kruger YA. NO-therapy in the treatment of purulent and necrotic lesions of lower extremities in diabetic patients. Khirurgiia. 2004;12:43-6.
56. Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol. 1992;26:590-3.
57. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and lowdose oral isotretinoin in rosacea. Arch Dermatol. 1994;130:319-24.
58. Forton F. Demodex et inflammation perifolliculaire chez l’homme revue et observation de 69 biopsies. Ann Dermatol Venereol. 1986;113:1047-58.
59. Erbagci Z, Ozgoztasi O. The significance of Demodex folliculorum density in rosacea.Int J Dermatol. 1998;37:421-5.
60. Rufli T, Mumcuoglu Y, Cajacob A, Buechner S. Demodex folliculorum: Zur Aetiopathogenese und Therapie der Rosazea und der perioralen Dermatitis. Dermatologica. 1981;162:12-26.
61. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol 1993;28:443-8.
62. Seifert HW. Demodex folliculorum als Ursache eines solitären tuberkuloiden Granulomas. Z Hautkr 1977;53:540-2.
63. Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett. 2007;12:1-5.
64. Koçak M, Yagli S, Vahapoglu G, Ekioglu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. a randomized double-blind placebocontrolled study. Dermatology. 2002;205:265-70.
65. McClellan K, Noble S. Topical metronidazole. Am J Clin Dermatol 2000; 1:191-199.
66. Van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol. 2007;56:107-15.
67. International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to ultraviolet radiation of wavelengths between 180 and 400 nm (incoherent optical radiation). Health Phys. 2004;87:171-86.
68. Daeschlein G, Darm K, Majunke S, Kindel E, Weltmann KD, Juenger M. et al. In vivo monitoring of atmospheric pressure plasma jet (APPJ) skin therapy by confocal laserscan microscopy. Second International Conference on Plasma Medicine, 2009 March 16-20; San Antonio.